Millennium Management’s Aurinia Pharmaceuticals AUPH Stock Holding History
Bought
Maintained
Sold
Other funds holding AUPH
TCM
NMC
Millennium Management's AUPH Position: Q2 2026 in Review
Millennium Management increased its Aurinia Pharmaceuticals (AUPH) stake by 109% in Q2 2026, buying an estimated $2.03M and bringing the position to 244,302 shares worth $4.15M. The position accounts for ﹤0.01% of the portfolio, ranked #3171.
Millennium Management first reported a position in AUPH in Q1 2015 and has held it in 37 quarters since. The position peaked at $39.4M in Q4 2019. 283 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.
- Millennium Management held 244,302 shares of Aurinia Pharmaceuticals worth $4.15M as of Q2 2026.
- Millennium Management bought 127,133 Aurinia Pharmaceuticals shares in Q2 2026, an estimated $2.03M.
- Aurinia Pharmaceuticals made up ﹤0.01% of Millennium Management's portfolio in Q2 2026, its #3171 holding.
- Millennium Management first reported a position in Aurinia Pharmaceuticals in Q1 2015 and has held it in 37 quarters since.
- Millennium Management's Aurinia Pharmaceuticals position peaked at $39.4M in Q4 2019.
- 283 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.
Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.